Suppressing the Aging Phenotype of Mesenchymal Stromal Cells
Author Information
Author(s): Roato Ilaria, Visca Matteo, Mussano Federico
Primary Institution: Department of Surgical Sciences, CIR-Dental School, University of Turin, Italy
Hypothesis
Can we effectively suppress the aging phenotype of mesenchymal stromal cells for clinical applications?
Conclusion
The study reviews various strategies to delay or revert the senescence of mesenchymal stromal cells, which is crucial for their therapeutic efficacy.
Supporting Evidence
- MSCs are crucial for tissue maintenance and regeneration due to their ability to differentiate into various cell types.
- Cellular senescence in MSCs is linked to reduced regenerative potential and altered paracrine secretion.
- Strategies to delay senescence include antioxidant treatments and modulation of signaling pathways.
Takeaway
This study looks at how to keep stem cells young and healthy so they can help heal people better.
Methodology
The authors reviewed current literature on the causes of senescence in mesenchymal stromal cells and therapeutic approaches to counteract it.
Limitations
The review highlights the need for more studies to understand the mechanisms of stem cell aging and the potential off-target effects of anti-senescent therapies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website